Mirae Asset Global Etfs Holdings Ltd. Recursion Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 165,062 shares of RXRX stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
165,062
Previous 157,123
5.05%
Holding current value
$1.74 Million
Previous $1.04 Million
7.73%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RXRX
# of Institutions
331Shares Held
276MCall Options Held
2.53MPut Options Held
2.68M-
Vanguard Group Inc Valley Forge, PA34MShares$358 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$341 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$262 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$182 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$154 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.9B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...